Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Balance Sheet and Related Statements of Operations and Cash Flows - Schedule of Restatement (Details)

v3.8.0.1
Restatement of Condensed Consolidated Balance Sheet and Related Statements of Operations and Cash Flows - Schedule of Restatement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Total other expense, net $ 21 $ (2,563) $ 1,311 $ (3,467)  
Total net loss/comprehensive loss $ (1,703) (5,064) $ (2,215) (8,452)  
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A preferred stock      
Net loss attributable to common stockholders $ (1,703) $ (5,064) $ (2,215) $ (8,452)  
Net loss per share attributable to common stockholders Basic and diluted $ (0.56) $ (4.76) $ (0.76) $ (8.46)  
Weighted average common shares outstanding: Basic and diluted 3,022,073 1,063,485 2,918,240 998,489  
Common stock, $0.01 par value $ 30   $ 30   $ 22
Additional paid-in capital 225,491   225,491   222,513
Accumulated deficit (213,254)   (213,254)   (211,300)
Total stockholders' equity 12,267   12,267   11,235
Derivative liabilities, current portion 1,776   1,776   $ 3,137
Scenario, Previously Reported [Member]          
Total other expense, net (382)   (730)    
Total net loss/comprehensive loss $ (2,106)   $ (4,256)    
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A preferred stock      
Net loss attributable to common stockholders $ (2,106)   $ (4,256)    
Net loss per share attributable to common stockholders Basic and diluted $ (0.06)   $ (0.12)    
Weighted average common shares outstanding: Basic and diluted 3,022,073   2,918,240    
Common stock, $0.01 par value $ 30   $ 30    
Additional paid-in capital 231,404   231,404    
Accumulated deficit (217,391)   (217,391)    
Total stockholders' equity 14,043   14,043    
Derivative liabilities, current portion